TP53 and breast carcinoma: For instance, NUAK2 expression was positively correlated with survival in overall, TNBC, ER-, and all intrinsic molecular subtypes, but negatively associated with survival in ER+ and WTp53, and had no correlation in mutant p53 breast cancer.